Dr. Marc E Rothenberg, MD, PhD
Claim this profileCincinnati Children's Hospital Medical Center
Studies Eosinophilic Esophagitis
Studies Hemophilia (or Haemophilia)
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Marc E Rothenberg, MD, PhD is currently running
Mepolizumab
for Hypereosinophilic Syndrome
The purpose of this study is to investigate the efficacy and safety of mepolizumab in children and adolescents with hypereosinophilic syndrome (HES) who are receiving standard of care (SoC) therapy.
Recruiting2 awards Phase 37 criteria
Depemokimab
for Hypereosinophilic Syndrome
This trial is testing a new medication called depemokimab for adults with Hypereosinophilic Syndrome (HES) who are not responding well to their current treatments. The medication aims to lower the number of certain white blood cells that cause symptoms to worsen. Participants will either receive depemokimab or continue their usual treatment.
Recruiting1 award Phase 35 criteria
More about Marc E Rothenberg, MD, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Marc E Rothenberg, MD, PhD has experience with
- Alpha-proteinase Inhibitor
- Dupilumab
- Placebo
- Mepolizumab
- Depemokimab
Breakdown of trials Marc E Rothenberg, MD, PhD has run
Eosinophilic Esophagitis
Hemophilia (or Haemophilia)
Postprandial Fullness Syndrome
Hypereosinophilic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc E Rothenberg, MD, PhD specialize in?
Marc E Rothenberg, MD, PhD focuses on Eosinophilic Esophagitis and Hemophilia (or Haemophilia). In particular, much of their work with Eosinophilic Esophagitis has involved treating patients, or patients who are undergoing treatment.
Is Marc E Rothenberg, MD, PhD currently recruiting for clinical trials?
Yes, Marc E Rothenberg, MD, PhD is currently recruiting for 3 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Marc E Rothenberg, MD, PhD has studied deeply?
Yes, Marc E Rothenberg, MD, PhD has studied treatments such as Alpha-proteinase inhibitor, Dupilumab, Placebo.
What is the best way to schedule an appointment with Marc E Rothenberg, MD, PhD?
Apply for one of the trials that Marc E Rothenberg, MD, PhD is conducting.
What is the office address of Marc E Rothenberg, MD, PhD?
The office of Marc E Rothenberg, MD, PhD is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.